Personalized medical treatment strategies for patients with chronic myeloid leukemia

Catherine Burton, David Marin, Jane Apperley

Research output: Contribution to journalReview articlepeer-review

Abstract

Management of patients with chronic myeloid leukemia has become increasingly difficult over the last few years since there are a variety of treatment options available. The ultimate challenge is to decide the most appropriate treatment strategy for an individual patient. To facilitate this, assessment of an individual patient's disease in terms of status, tempo and response to initial treatment needs to be determined. This review article discusses the current treatment options in the management of chronic myeloid leukemia, the factors that influence management decisions and suggests how treatment for the individual patient may be tailored whilst involving the patient in the decision-making process.

Original languageEnglish (US)
Pages (from-to)343-353
Number of pages11
JournalExpert review of anticancer therapy
Volume5
Issue number2
DOIs
StatePublished - Apr 2005

Keywords

  • Accelerated phase
  • Allogenic transplantation
  • Autologous transplantation
  • Blast phase
  • Chronic myeloid leukemia (CML)
  • Chronic phase
  • Hydroxyurea
  • Imatinib
  • Interferon-α
  • Reduced intensity conditioned transplantation

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Personalized medical treatment strategies for patients with chronic myeloid leukemia'. Together they form a unique fingerprint.

Cite this